OpenAI and Thrive Capital Back AI Drug Discovery Startup

A startup focused on developing new drugs using artificial intelligence technologies has caught the attention of giants like OpenAI and Thrive Capital. This just six-month-old project has secured significant funding from well-known investors, underscoring the growing interest in applying AI to medicine.

Continue reading